Frank Donath

943 total citations
33 papers, 646 citations indexed

About

Frank Donath is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Frank Donath has authored 33 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Frank Donath's work include Cardiac electrophysiology and arrhythmias (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Frank Donath is often cited by papers focused on Cardiac electrophysiology and arrhythmias (5 papers), Analytical Methods in Pharmaceuticals (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Frank Donath collaborates with scholars based in Germany, United States and Netherlands. Frank Donath's co-authors include Henning Blume, Barbara Schug, Ivar Roots, Konstanze Diefenbach, Ingo Fietze, Hans‐Heinrich Henneicke‐von Zepelin, Gerhard Arold, M. Friede, Steffen Bauer and Ralph‐Steven Wedemeyer and has published in prestigious journals such as Circulation, Journal of Controlled Release and European Heart Journal.

In The Last Decade

Frank Donath

29 papers receiving 591 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Donath Germany 13 149 97 90 81 75 33 646
G. Dobos Germany 13 203 1.4× 51 0.5× 90 1.0× 31 0.4× 46 0.6× 41 955
N. A. Klitgaard Denmark 20 51 0.3× 89 0.9× 98 1.1× 188 2.3× 18 0.2× 68 1.1k
Christian de Mey Germany 22 93 0.6× 75 0.8× 270 3.0× 342 4.2× 63 0.8× 104 1.3k
A Castot France 14 139 0.9× 278 2.9× 51 0.6× 44 0.5× 8 0.1× 61 897
Yukinao Kohda Japan 19 25 0.2× 216 2.2× 224 2.5× 129 1.6× 84 1.1× 115 1.3k
Dorin Dragoș Romania 14 44 0.3× 37 0.4× 96 1.1× 53 0.7× 9 0.1× 48 703
Abeer Rababa’h Jordan 17 36 0.2× 26 0.3× 112 1.2× 216 2.7× 14 0.2× 67 790
Ashish Sharma India 15 40 0.3× 105 1.1× 35 0.4× 81 1.0× 7 0.1× 46 874
Beom‐Joon Lee South Korea 17 209 1.4× 147 1.5× 54 0.6× 16 0.2× 63 0.8× 104 844

Countries citing papers authored by Frank Donath

Since Specialization
Citations

This map shows the geographic impact of Frank Donath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Donath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Donath more than expected).

Fields of papers citing papers by Frank Donath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Donath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Donath. The network helps show where Frank Donath may publish in the future.

Co-authorship network of co-authors of Frank Donath

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Donath. A scholar is included among the top collaborators of Frank Donath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Donath. Frank Donath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Düngen, Hans‐Dirk, Frank Donath, Rainard Fuhr, et al.. (2023). Vericiguat: A Randomized, Phase Ib, Placebo-Controlled, Double-Blind, QTc Interval Study in Patients with Chronic Coronary Syndromes. American Journal of Cardiovascular Drugs. 23(2). 145–155. 9 indexed citations
2.
Böettcher, Michael, Hans‐Dirk Düngen, Frank Donath, et al.. (2022). Vericiguat in Combination with Short‐Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study. Clinical Pharmacology & Therapeutics. 111(6). 1239–1247. 9 indexed citations
3.
Koziolek, Mirko, et al.. (2021). Development of a furosemide-containing expandable system for gastric retention. Journal of Controlled Release. 338. 105–118. 12 indexed citations
4.
Donath, Frank, et al.. (2021). Intravaginal Tolterodine Formulation Intended for Overactive Bladder Treatment—Results of a Pharmacokinetic Phase I Pilot Study in Healthy, Postmenopausal Women. Clinical Pharmacology in Drug Development. 11(1). 80–90. 3 indexed citations
5.
Böettcher, Michael, V Corcea, Frank Donath, et al.. (2021). Vericiguat: a QTc interval study in patients with coronary artery disease. European Heart Journal. 42(Supplement_1). 2 indexed citations
6.
Rengelshausen, Jens, Frank Donath, Timothy C. Hardman, et al.. (2021). How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum. Therapeutic Innovation & Regulatory Science. 55(3). 612–618.
7.
Donath, Frank, et al.. (2021). Pharmacokinetics of oral pridinol: Results of a randomized, crossover bioequivalence trial in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics. 59(6). 471–477. 3 indexed citations
8.
Garofolo, Fabio, et al.. (2020). A novel rizatriptan oral gel formulation: Bioavailability and bioequivalence. International Journal of Clinical Pharmacology and Therapeutics. 58(10). 583–594. 1 indexed citations
9.
Donath, Frank, et al.. (2017). Abstract 19938: VEriciguat NItroglycerin Clinical IntEraction (VENICE): A Phase 1, Multicenter, Randomized, Placebo-controlled, Double-blind Group-comparison Study in Patients With Stable Coronary Artery Disease to Evaluate Tolerability and Blood Pressure Effects of Nitroglycerin After Pre-treatment With Multiple Oral Doses of Vericiguat. Circulation. 3 indexed citations
10.
Coch, Christoph, Martin Coenen, Frank Donath, et al.. (2017). Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials. European Journal of Clinical Pharmacology. 73(4). 409–416. 16 indexed citations
11.
Schug, Barbara, Frank Donath, & Henning Blume. (2011). Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers. International Journal of Clinical Pharmacology and Therapeutics. 50(2). 100–117. 2 indexed citations
12.
13.
Donath, Frank, et al.. (2011). The influence of propiverine hydrochloride on cardiac repolarization in healthy women and cardiac male patients. International Journal of Clinical Pharmacology and Therapeutics. 49(6). 353–365. 6 indexed citations
14.
Wonnemann, Meinolf, et al.. (2010). Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration. International Journal of Clinical Pharmacology and Therapeutics. 48(2). 158–170. 15 indexed citations
15.
Garbacz, Grzegorz, Olaf Kosch, Frank Donath, et al.. (2009). Characterization of the behavior of alginate-based microcapsules in vitro and in vivo. International Journal of Clinical Pharmacology and Therapeutics. 47(9). 556–563. 4 indexed citations
16.
Harder, Sebastian, et al.. (2008). Biomarkers and Coagulation Tests for Assessing the Biosimilarity of a Generic Low‐Molecular‐Weight Heparin: Results of a Study in Healthy Subjects With Enoxaparin. The Journal of Clinical Pharmacology. 48(10). 1189–1196. 19 indexed citations
17.
Christ, Torsten, Erich Wettwer, Melinda Wuest, et al.. (2007). Electrophysiological profile of propiverine – relationship to cardiac risk. Naunyn-Schmiedeberg s Archives of Pharmacology. 376(6). 431–440. 13 indexed citations
18.
Blume, Henning, et al.. (2006). Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors. Drug Safety. 29(9). 769–784. 162 indexed citations
19.
Arold, Gerhard, Frank Donath, Konstanze Diefenbach, et al.. (2005). No Relevant Interaction with Alprazolam, Caffeine, Tolbutamide, and Digoxin by Treatment with a Low-Hyperforin St John’s Wort Extract. Planta Medica. 71(4). 331–337. 70 indexed citations
20.
Donath, Frank, et al.. (1996). Oral bioavailability of bromelain and trypsin after repeated oral administration of a commercial polyenzyme preparation. European Journal of Clinical Pharmacology. 50(6). 548. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Dobos Breakdown of academic impact, for papers by N. A. Klitgaard Breakdown of academic impact, for papers by Christian de Mey Breakdown of academic impact, for papers by A Castot Breakdown of academic impact, for papers by Yukinao Kohda Breakdown of academic impact, for papers by Dorin Dragoș Breakdown of academic impact, for papers by Abeer Rababa’h Breakdown of academic impact, for papers by Ashish Sharma Breakdown of academic impact, for papers by Beom‐Joon Lee
Rankless by CCL
2026